Advisor Group’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
NIM
WAM
FHA
CA
KIM
AAM
Advisor Group's HQL Position: Q4 2019 in Review
Advisor Group increased its abrdn Life Sciences Investors (HQL) stake by 6.4% in Q4 2019, buying an estimated $71.2K and bringing the position to 72,236 shares worth $1.26M. The position accounts for 0.01% of the portfolio, ranked #1061.
Advisor Group first reported a position in HQL in Q2 2016 and has held it in 15 quarters since. 69 funds tracked by Wall St. Rank hold HQL as of Q4 2019.
- Advisor Group held 72,236 shares of abrdn Life Sciences Investors worth $1.26M as of Q4 2019.
- Advisor Group bought 4,338 abrdn Life Sciences Investors shares in Q4 2019, an estimated $71.2K.
- abrdn Life Sciences Investors made up 0.01% of Advisor Group's portfolio in Q4 2019, its #1061 holding.
- Advisor Group first reported a position in abrdn Life Sciences Investors in Q2 2016 and has held it in 15 quarters since.
- 69 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2019.
Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.